Submitted by Administrator on Wed, 12/06/2019 - 07:51
Professor Nicole Soranzo (Dept Haematology & Wellcome Sanger Institute) has joined 48 fellow scientists from 17 countries in being elected as Members of the European Molecular Biology Organization (EMBO). An additional eight researchers from Argentina, Australia, Japan and the US have become Associate Members of the organisation whose mission is to promote excellence in European molecular life sciences research.
Prof Soranzo leads the Functional Genomics research theme in the Cambridge BHF Centre of Research Excellence. The theme will discover and validate gene targets for vascular disease - including pulmonary arterial hypertension (PAH) and cerebral small vessel disease (SVD).
At the Wellcome Sanger Institute, Prof Soranzo focuses on understanding the role of genetics and molecular pathways in determining cardiovascular health. She is especially interested in the relationship between metabolic pathways and signalling in blood cell development and the impact this has on diseases ranging from heart disease to blood clotting and inflammatory disorders.
As an EMBO Member, Prof Soranzo will play an active role in helping to guide the organisation’s activities by serving on committees, evaluating funding applications and mentoring young scientists. The latter role is particularly close to her heart; at the Wellcome Sanger Institute, Nicole chairs the Postdoctoral Research Fellows committee that supports the training, career development and mentoring of the next generation of genomics research leaders.
Ever since the very first EMBO Council in 1963, new members are nominated and elected by the existing membership. The new members will be formally welcomed at the Annual Members’ Meeting in Heidelberg between 29 and 31 October 2019.
The original announcement can be found on the Wellcome Sanger Institute website.
